Dr. Wong is an infectious disease physician with an expertise in the management of complicated infections. Prior to joining USC-faculty, he received his training at tertiary university referral hospitals in both Philadelphia and New York City.
Dr. Wong’s current research is focused on examining empiric antibiotic therapy for sepsis. He has a particular focus on the management of multi-drug resistant bacterial infections and Clostridium difficile disease. Additionally, he is very committed to medical education and has significant teaching responsibilities for resident and fellow doctors-in-training. He is also actively involved in hospital infection control and antimicrobial stewardship, and the integration both programs to optimize clinical care.
2018 Southern California Super Doctors Rising Stars List
2017 Southern California Super Doctors Rising Stars List
Montefiore Medical Center: Leo M. Davidoff Society Award for Outstanding Achievement in Teaching, 2014
. View in: PubMed
Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae. Virulence. 2017 May 19; 8(4):383-390. View in: PubMed
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy. Drugs. 2017 Apr; 77(6):615-628. View in: PubMed
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy. Drugs. 2017 Mar 16. View in: PubMed
A case of liver abscess and fusobacterium septicemia. IDCases. 2017; 9:98-100. View in: PubMed
Facklamia Species as an Underrecognized Pathogen. Open Forum Infect Dis. 2017; 4(1):ofw272. View in: PubMed
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev. 2017 Jan; 30(1):409-447. View in: PubMed
Leveraging Antimicrobial Stewardship into Improving Rates of Carbapenem-Resistant Enterobacteriaceae. Virulence. 2016 May 17; 0. View in: PubMed
Anti-NMDAR encephalitis, a mimicker of acute infectious encephalitis and a review of the literature. IDCases. 2014; 1(4):66-7. View in: PubMed